Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA central management functions to receive $7.8 mil. from user fees in FY '97 -- Senate cmte..

Executive Summary

FDA POLICY AND MANAGEMENT FUNCTIONS WILL USE $7.8 MIL. IN USER FEES during fiscal 1997, according to the Senate Appropriations Committee report on the appropriations bill for FDA and related agencies adopted by a 26-0 vote July 11. The committee report for the first time breaks out the funding levels for FDA's offices of the commissioner, policy, external affairs, and management and systems as well as orphan product and other extramural grants and central services. The total cost of those activities in fiscal 1997 is budgeted at $113.8 mil., with $7.8 mil. paid for from prescription drug and mammography user fees, the report states.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel